MiR-34b regulates cervical cancer cell proliferation and apoptosis

Reference

• Silva GAF, Nunes RAL, Morale MG, et al. Oxidative stress: therapeutic approaches for cervical cancer treatment. Clinics (Sao Paulo) 2018;73:e548s.
   PubMed Web of Science ®Google Scholar
• Gauri A, Messiah SE, Bouzoubaa LA, et al. Cervical cancer sociodemographic and diagnostic disparities in Florida: a population-based study (1981–2013) by stage at presentation. Ethn Health. 2018;1–9.
   PubMed Web of Science ®Google Scholar
• Teoh D, Hultman G, DeKam M, et al. Excess cost of cervical cancer screening beyond recommended screening ages or after hysterectomy in a single institution. J Low Genit Tract Dis. 2018;22:184–188.
   PubMed Web of Science ®Google Scholar
• Berman TA, Schiller JT. Human papillomavirus in cervical cancer and oropharyngeal cancer: one cause, two diseases. Cancer 2017;123:2219–2229.
   PubMed Web of Science ®Google Scholar
• Fan Y, Meng Y, Yang S, et al. Screening of cervical cancer with self-collected cervical samples and next-generation sequencing. Dis Markers. 2018;2018:4826547.
   PubMed Web of Science ®Google Scholar
• Mohr AM, Mott JL. Overview of microRNA biology. Semin Liver Dis. 2015;35:3–11.
   PubMed Web of Science ®Google Scholar
• Rodrigues Lopes I, Silva RJ, Caramelo I, et al. Shedding light on microRNA function via microscopy-based screening. Methods. 2019;152:55–64.
   PubMed Web of Science ®Google Scholar
• Ozbey U, Attar R, Romero MA, et al. Apigenin as an effective anticancer natural product: spotlight on TRAIL, WNT/beta-catenin, JAK-STAT pathways, and microRNAs. J Cell Biochem. 2018;120:1060–1067.
   PubMed Web of Science ®Google Scholar
• Ren C, Liu Q, Wei Q, et al. Circulating miRNAs as potential biomarkers of age-related macular degeneration. Cell Physiol Biochem. 2017;41:1413–1423.
   PubMed Web of Science ®Google Scholar
• Han MS, Lee JM, Kim SN, et al. Human papillomavirus 16 oncoproteins downregulate the expression of miR-148a-3p, miR-190a-5p, and miR-199b-5p in cervical cancer. Biomed Res Int. 2018;2018:1942867.
   PubMed Web of Science ®Google Scholar
• Santos JMO, Peixoto da Silva S, Costa NR, et al. The role of microRNAs in the metastatic process of high-risk HPV-induced cancers. Cancers (Basel) 2018;10:493–508.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang L, Dong D, et al. MiR-34b/c-5p and the neurokinin-1 receptor regulate breast cancer cell proliferation and apoptosis. Cell Prolif. 2019;52:e12527.
   PubMed Web of Science ®Google Scholar
• Dou YD, Huang T, Wang Q, et al. Integrated microRNA and mRNA signatures in peripheral blood lymphocytes of familial epithelial ovarian cancer. Biochem Biophys Res Commun. 2018;496:191–198.
   PubMed Web of Science ®Google Scholar
• Wang AM, Huang TT, Hsu KW, et al. Yin Yang 1 is a target of microRNA-34 family and contributes to gastric carcinogenesis. Oncotarget 2014;5:5002–5016.
   PubMedGoogle Scholar
• Hashemi M, Moazeni-Roodi A, Bahari G, et al. Association between miR-34b/c rs4938723 polymorphism and risk of cancer: an updated meta-analysis of 27 case-control studies. J Cell Biochem. 2019;120:3306–3314.
   PubMed Web of Science ®Google Scholar
• Hashemi M, Hasanpour V, Danesh H, et al. Association between Pri-miR-34b/c rs4938723 polymorphism and bladder cancer risk. J Biomed Res. 2018;33:24–29.
   PubMed Web of Science ®Google Scholar
• Revathidevi S, Manikandan M, Rao AK, et al. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation. Tumour Biol. 2016;37:11983–11990.
   PubMedGoogle Scholar
• Cheung TH, Man KN, Yu MY, et al. Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle. 2012;11:2876–2884.
   PubMed Web of Science ®Google Scholar
• Liu M, Wang Z, Liu Q, et al. Expression of micro-RNA-492 (MiR-492) in human cervical cancer cell lines is upregulated by transfection with wild-type P53, irradiation, and 5-fluorouracil treatment in vitro. Med Sci Monit. 2018;24:7750–7758.
   PubMed Web of Science ®Google Scholar
• Dong J, Wang M, Ni D, et al. MicroRNA-217 functions as a tumour suppressor in cervical cancer cells through targeting Rho-associated protein kinase 1. Oncol Lett. 2018;16:5535–5542.
   PubMed Web of Science ®Google Scholar
• Li H, Li X, Ge X, et al. MiR-34b-3 and miR-449a inhibit malignant progression of nasopharyngeal carcinoma by targeting lactate dehydrogenase A. Oncotarget 2016;7:54838–54851.
   PubMedGoogle Scholar
• Dong F, Lou D. MicroRNA-34b/c suppresses uveal melanoma cell proliferation and migration through multiple targets. Mol Vis. 2012;18:537–546.
   PubMed Web of Science ®Google Scholar
• Xiao W, Zhou S, Xu H, et al. Nogo-B promotes the epithelial-mesenchymal transition in HeLa cervical cancer cells via r cells via Fibulin-5. Oncol Rep. 2013;29:109–116.
   PubMed Web of Science ®Google Scholar
• Zhang F, Ren CC, Liu L, et al. HOXC6 gene silencing inhibits epithelial-mesenchymal transition and cell viability through the TGF-β/smad signaling pathway in cervical carcinoma cells. Cancer Cell Int. 2018;18:204.
   PubMed Web of Science ®Google Scholar
• Wang A, Zhang Y, Cao P. Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis. Biochem Biophys Res Commun. 2019;508:499–506.
   PubMed Web of Science ®Google Scholar